Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I S Johnson

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Diabetes Care|November 1, 1982
Authenticity and purity of human insulin (recombinant DNA)I S Johnson
The New England Journal of Medicine|August 28, 1980
Gene cloning by press conferenceI S Johnson
Science (New York, N.Y.)|August 14, 1992
Drugs from Third World plantsI S Johnson
Science (New York, N.Y.)|April 20, 1984
Role of the Recombinant Advisory CommitteeI S Johnson
BMJ (Clinical Research Ed.)|September 4, 1993
Complementary medicine. Acupuncture has weak scientific foundationsI S Johnson
Science (New York, N.Y.)|July 6, 1984
In reply: regulation of biotechnologyI S Johnson
Palliative Medicine|April 17, 2001
Use of bisphosphonates for the treatment of metastatic bone pain. A survey of palliative physicians in the UKI S Johnson
Science (New York, N.Y.)|April 9, 1993
Drugs from Third World plants: creative approachesI S Johnson
Science (New York, N.Y.)|February 11, 1983
Human insulin from recombinant DNA technologyI S Johnson
Journal of Epidemiology and Community Health|September 1, 1989
Screening for ischaemic heart disease risk factors at a health fair: low attendance by those at highest riskM Watts, I S Johnson
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Diabetes Care|November 1, 1982
Authenticity and purity of human insulin (recombinant DNA)I S Johnson
The New England Journal of Medicine|August 28, 1980
Gene cloning by press conferenceI S Johnson
Science (New York, N.Y.)|August 14, 1992
Drugs from Third World plantsI S Johnson
Science (New York, N.Y.)|April 20, 1984
Role of the Recombinant Advisory CommitteeI S Johnson
BMJ (Clinical Research Ed.)|September 4, 1993
Complementary medicine. Acupuncture has weak scientific foundationsI S Johnson
Science (New York, N.Y.)|July 6, 1984
In reply: regulation of biotechnologyI S Johnson
Palliative Medicine|April 17, 2001
Use of bisphosphonates for the treatment of metastatic bone pain. A survey of palliative physicians in the UKI S Johnson
Science (New York, N.Y.)|April 9, 1993
Drugs from Third World plants: creative approachesI S Johnson
Science (New York, N.Y.)|February 11, 1983
Human insulin from recombinant DNA technologyI S Johnson
Journal of Epidemiology and Community Health|September 1, 1989
Screening for ischaemic heart disease risk factors at a health fair: low attendance by those at highest riskM Watts, I S Johnson
Pageof 3